UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
D D D- D0 D1 D2 D5 D7 D8 D9 DA DB DC DD DE DF DG DH DI DJ DK DL DM DN DO DP DR DS DT DU DV DW DX DY
DHA DHE DHF DHI DHO DHP
selected terms: 40 page 1 of 1

1. D-His-6-Pro-8-NEt-LHRH
[LH-RH. A hormone that stimulates the production of sex hormones in men and women. ( NCI )] (UMLS (NCI) C0023610) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone =[HS400] GONADOTROPINS;
Hypothalamic Hormone;
neuropeptide;
oligopeptide =6-D-(2-naphthyl)alanyl-GnRH;
ganirelix;
6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig);
6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide;
GONADORELIN ACETATE;
GONADORELIN HYDROCHLORIDE;
GONADORELIN ACETATE;
GONADORELIN HYDROCHLORIDE;
21. DHAD/PRED/VCR/VP-16
(UMLS (NCI) C0281404) =Therapeutic or Preventive Procedure ;
2. DHA-Paclitaxel
[A combination of DHA (a natural fatty acid) and paclitaxel (an anticancer drug) that is being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C1134470) Docosahexaenoic Acid-Paclitaxel conjugate;
TXP =Organic Chemical; Pharmacologic Substance ;
22. DHAD/PSC 833/VP-16
(UMLS (NCI) C0281726) =Therapeutic or Preventive Procedure
3. DHA-Paclitaxel/Gemcitabine
(UMLS (NCI) C1327871) =Therapeutic or Preventive Procedure ;
23. DHAD/TAX
(UMLS (NCI) C0281593) =Therapeutic or Preventive Procedure
4. DHAC
[A synthetic nucleoside analogue of deoxycytidine. Dihydro-5-azacytidine inhibits DNA methyltransferase, thereby interfering with abnormal DNA methylation patterns that are associated with genetic instability in some tumor cells. Inhibition of this enzyme may restore expression of tumor-suppressor genes and result in antitumor activity. (NCI04) ( NCI )] (UMLS (NCI) C0048906) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
24. DHAD/TAX/TSPA
(UMLS (NCI) C0281473) =Therapeutic or Preventive Procedure
5. DHAD/5-FU/MTX
(UMLS (NCI) C0083765) =Therapeutic or Preventive Procedure ;
25. DHAD/TOPO/TSPA
(UMLS (NCI) C0678042) =Therapeutic or Preventive Procedure ;
6. DHAD/FAMP
(UMLS (NCI) C0281747) =Therapeutic or Preventive Procedure
26. DHAD/TSPA
(UMLS (NCI) C0280683) =Therapeutic or Preventive Procedure
7. DHAD/GM-CSF
(UMLS (NCI) C0279103) =Therapeutic or Preventive Procedure
27. DHAD/TSPA/VP-16
(UMLS (NCI) C0280523) =Therapeutic or Preventive Procedure
8. DHAD/GM-CSF/VP-16
(UMLS (NCI) C0281674) =Therapeutic or Preventive Procedure
28. DHAD/VNB
(UMLS (NCI) C0677974) =Therapeutic or Preventive Procedure
9. DHAD/HC
(UMLS (NCI) C0281308) =Therapeutic or Preventive Procedure ;
29. DHAD/VP-16
(UMLS (NCI) C0279049) =Therapeutic or Preventive Procedure
10. DHAD/IFF
(UMLS (NCI) C0280505) =Therapeutic or Preventive Procedure ;
30. DHE
[The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. ( MSH )] (UMLS (NCI) C0058031) =Organic Chemical; Pharmacologic Substance ;
11. DHAD/IFF/mesna
(UMLS (NCI) C0393048) =Therapeutic or Preventive Procedure
31. DHE/OMEP
(UMLS (NCI) C0678018) =Therapeutic or Preventive Procedure
12. DHAD/IFF/mesna/VP-16
(UMLS (NCI) C0338297) =Therapeutic or Preventive Procedure
32. DHEA Analog 8354
(UMLS (NCI) C0539514) =Steroid; Pharmacologic Substance ;
13. DHAD/IFF/VP-16
(UMLS (NCI) C0280689) =Therapeutic or Preventive Procedure
33. Dhegiha
(UMLS (HL7) C1699696) =Language =MississippiValley;
=Osage;
Omaha-Ponca;
Kansa;
Alkansea;
14. DHAD/IFN-A
(UMLS (NCI) C0338108) =Therapeutic or Preventive Procedure ;
34. DHFR
[Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. It is a drug target. Variation in gene expression or sequence may alter the efficacy of chemotherapy. (from LocusLink and NCI) ( NCI )] (UMLS (NCI) C0039667) =Amino Acid, Peptide, or Protein; Enzyme ;
=amine oxidoreductase;
Genes, Reporter
15. DHAD/L-ATRA/VP-16
(UMLS (NCI) C0338224) =Therapeutic or Preventive Procedure
35. DHFR
[This gene is involved in biosynthesis, nucleotide metabolism and the immune response. ( NCI )] (UMLS (NCI) C1333216) DHFR Gene;
Dihydrofolate Reductase Gene =Gene or Genome ;
16. DHAD/L-PAM
(UMLS (NCI) C0392932) =Therapeutic or Preventive Procedure ;
36. DHFR Inhibitor
[Substances that inhibit Dihydrofolate Reductase interfering with the conversion of Dihydrofolate to Tetrahydrofolate, causing inhibition of nucleotide biosynthesis and protein synthesis. ( NCI )] (UMLS (NCI) C1373048) Dihydrofolate Reductase Inhibitor;
Dihydrofolate Reductase Inhibitors;
=Pharmacologic Substance ;
=antifolate;
17. DHAD/MGBG/VBL/VP-16
(UMLS (NCI) C0280467) =Therapeutic or Preventive Procedure
37. DHODH
[This gene plays a role in pyrimidine metabolism. ( NCI )] (UMLS (NCI) C1333217) DHODH Gene;
Dihydroorotate Dehydrogenase Gene =Gene or Genome ;
18. DHAD/PCB/PRED/VCR
(UMLS (NCI) C0255600) =Therapeutic or Preventive Procedure
38. Dhori virus
[ ] (UMLS (CSP) C0206549) =Virus
19. DHAD/PM/VP-16
(UMLS (NCI) C0279110) =Therapeutic or Preventive Procedure
39. DHP
[partially saturated derivative of pyridine; binds to and inhibits the voltage-gated calcium channel of skeletal muscle T junctional membranes, the principle molecular transducer of excitation-contraction coupling. ( CSP )] (UMLS (CSP) C0220821) =Organic Chemical; Pharmacologic Substance ;
=[CV200] CALCIUM CHANNEL BLOCKERS;
pyridine
20. DHAD/PRED
(UMLS (NCI) C0678009) =Therapeutic or Preventive Procedure
40. DHPG sodium
[The sodium salt form of ganciclovir, a synthetic, antiviral, purine nucleoside analog with antiviral activity, especially against cytomegalovirus (CMV). Ganciclovir sodium is a prodrug that is phosphorylated and subsequently converted into its triphosphate form, the active metabolite ganciclovir-5-triphosphate (ganciclovir-TP), in the infected cells by cellular kinases. Ganciclovir-TP competes as a substrate with nucleotide triphosphates for viral DNA polymerase. Once it gets incorporated into DNA strand, it prevents further polymerization of DNA, thereby interfering with viral DNA replication. ( NCI )] (UMLS (NCI) C0282399) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one;
=GANCICLOVIR (AS SODIUM) 500;
GANCICLOVIR (AS SODIUM) 250 MG

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM